Hector Esquer

470 total citations
16 papers, 373 citations indexed

About

Hector Esquer is a scholar working on Molecular Biology, Oncology and Endocrine and Autonomic Systems. According to data from OpenAlex, Hector Esquer has authored 16 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Oncology and 2 papers in Endocrine and Autonomic Systems. Recurrent topics in Hector Esquer's work include Cancer Cells and Metastasis (3 papers), Cancer therapeutics and mechanisms (3 papers) and Heme Oxygenase-1 and Carbon Monoxide (3 papers). Hector Esquer is often cited by papers focused on Cancer Cells and Metastasis (3 papers), Cancer therapeutics and mechanisms (3 papers) and Heme Oxygenase-1 and Carbon Monoxide (3 papers). Hector Esquer collaborates with scholars based in United States, Netherlands and Luxembourg. Hector Esquer's co-authors include Lisa M. Berreau, Abby D. Benninghoff, Livia S. Lazarus, Atta M. Arif, Daniel V. LaBarbera, Qiong Zhou, Wells A. Messersmith, Sébastien Rinaldetti, Laura A. Pike and Daniel L. Gustafson and has published in prestigious journals such as Journal of the American Chemical Society, Oncogene and Free Radical Biology and Medicine.

In The Last Decade

Hector Esquer

15 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hector Esquer United States 8 296 129 77 65 53 16 373
Miguel Chaves‐Ferreira Portugal 7 173 0.6× 80 0.6× 31 0.4× 46 0.7× 61 1.2× 9 372
Brian Kawahara United States 9 240 0.8× 42 0.3× 57 0.7× 43 0.7× 41 0.8× 11 406
Livia S. Lazarus United States 7 333 1.1× 167 1.3× 122 1.6× 87 1.3× 6 0.1× 7 432
Thomas Ming Swi Chang Canada 7 197 0.7× 178 1.4× 57 0.7× 35 0.5× 4 0.1× 12 400
A.R. Sørensen Denmark 9 409 1.4× 44 0.3× 26 0.3× 21 0.3× 29 0.5× 10 747
U. D. Larsen Denmark 11 416 1.4× 35 0.3× 14 0.2× 18 0.3× 77 1.5× 19 762
Maria A. Pospischil United States 9 163 0.6× 63 0.5× 6 0.1× 25 0.4× 68 1.3× 11 334
L.W.‐M. Fung United States 15 211 0.7× 169 1.3× 13 0.2× 37 0.6× 6 0.1× 25 458
Paul Root United States 9 128 0.4× 79 0.6× 100 1.3× 12 0.2× 4 0.1× 9 406
Jili Li China 13 192 0.6× 11 0.1× 131 1.7× 10 0.2× 24 0.5× 36 384

Countries citing papers authored by Hector Esquer

Since Specialization
Citations

This map shows the geographic impact of Hector Esquer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hector Esquer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hector Esquer more than expected).

Fields of papers citing papers by Hector Esquer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hector Esquer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hector Esquer. The network helps show where Hector Esquer may publish in the future.

Co-authorship network of co-authors of Hector Esquer

This figure shows the co-authorship network connecting the top 25 collaborators of Hector Esquer. A scholar is included among the top collaborators of Hector Esquer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hector Esquer. Hector Esquer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Sala, Rita, et al.. (2024). CHD1L Regulates Cell Survival in Breast Cancer and Its Inhibition by OTI-611 Impedes the DNA Damage Response and Induces PARthanatos. International Journal of Molecular Sciences. 25(16). 8590–8590. 3 indexed citations
3.
Sala, Rita, Hector Esquer, Paul Awolade, et al.. (2024). CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models. International Journal of Molecular Sciences. 25(23). 13160–13160. 1 indexed citations
4.
Awolade, Paul, Qiong Zhou, Hector Esquer, et al.. (2023). The validation of new CHD1L inhibitors as a therapeutic strategy for cancer. Biomedicine & Pharmacotherapy. 170. 116037–116037. 2 indexed citations
5.
Zhou, Qiong, Hector Esquer, Rita Sala, et al.. (2023). HTS discovery of PARP1-HPF1 complex inhibitors in cancer. SLAS DISCOVERY. 28(8). 394–401. 6 indexed citations
6.
Prigaro, Brett J., Hector Esquer, Qiong Zhou, et al.. (2022). Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L. Journal of Medicinal Chemistry. 65(5). 3943–3961. 11 indexed citations
7.
Marentette, John, Hector Esquer, Daniel V. LaBarbera, et al.. (2022). Oxidative stress as a candidate mechanism for accelerated neuroectodermal differentiation due to trisomy 21. Free Radical Biology and Medicine. 186. 32–42. 7 indexed citations
8.
Rinaldetti, Sébastien, Qiong Zhou, Hector Esquer, et al.. (2022). High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes. International Journal of Molecular Sciences. 23(18). 10605–10605. 2 indexed citations
9.
Esquer, Hector, Qiong Zhou, Travis Nemkov, et al.. (2021). Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer. Oncogene. 40(16). 2884–2897. 18 indexed citations
10.
Zhou, Qiong, Hector Esquer, Laura A. Pike, et al.. (2020). First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer. Molecular Cancer Therapeutics. 19(8). 1598–1612. 23 indexed citations
11.
Esquer, Hector, et al.. (2020). Advanced High-Content-Screening Applications of Clonogenicity in Cancer. SLAS DISCOVERY. 25(7). 734–743. 16 indexed citations
12.
Esquer, Hector, Qiong Zhou, Linfeng Li, et al.. (2019). Drug Design Targeting T-Cell Factor-Driven Epithelial–Mesenchymal Transition as a Therapeutic Strategy for Colorectal Cancer. Journal of Medicinal Chemistry. 62(22). 10182–10203. 12 indexed citations
13.
Lazarus, Livia S., et al.. (2018). Mitochondrial-Localized Versus Cytosolic Intracellular CO-Releasing Organic PhotoCORMs: Evaluation of CO Effects Using Bioenergetics. ACS Chemical Biology. 13(8). 2220–2228. 40 indexed citations
14.
Esquer, Hector, et al.. (2018). Glycolytic and redox control of neuronal excitability in vitro. Free Radical Biology and Medicine. 128. S131–S132.
15.
Lazarus, Livia S., Hector Esquer, Abby D. Benninghoff, & Lisa M. Berreau. (2017). Sense and Release: A Thiol-Responsive Flavonol-Based Photonically Driven Carbon Monoxide-Releasing Molecule That Operates via a Multiple-Input AND Logic Gate. Journal of the American Chemical Society. 139(28). 9435–9438. 117 indexed citations
16.
Esquer, Hector, et al.. (2015). A Structurally‐Tunable 3‐Hydroxyflavone Motif for Visible Light‐Induced Carbon Monoxide‐Releasing Molecules (CORMs). ChemistryOpen. 4(5). 590–594. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026